Related Articles
Long-term validation of a molecular progression-associated gene classifier for prediction of muscle invasion in primary non-muscle-invasive bladder cancer
Expression levels of FGFR3 as a prognostic marker for the progression of primary pT1 bladder cancer and its association with mutation status
RSPH9 methylation pattern as a prognostic indicator in patients with non-muscle invasive bladder cancer
The prognostic value of cadherin switch in bladder cancer
Decreased expression of galectin-3 predicts tumour recurrence in pTa bladder cancer